Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 2, 2026

Structure-Activity Relationships and Ligand-Dependent Arrestin Bias in μ-Opioid Receptor-Mediated ERK Activation.

View Full Paper
Ask AI
Bookmark
Share

Authors

LHLei HuangMWMengling WangDKDooti Kundu

Discussion

Loading...

Member takes

Overview

Randomized trial investigates arrestin's impact on ERK activation in μ-opioid receptor signaling, suggesting new drug design pathways.

Key Points

  • This research aims to clarify how different opioid ligands affect μ-opioid receptor signaling and arrestin interactions.
  • Conducted radioligand binding assays on 13 opioid compounds.
  • Analyzed structural determinants for binding affinity in fentanyl and non-fentanyl ligands.
  • Examined arrestin's role in ERK activation across different ligands.
  • Identified four structural determinants in fentanyl analogs crucial for μ-opioid receptor binding.
  • Showed structural flexibility in ligands like methadone enhances binding affinity compared to rigid scaffolds.
  • Demonstrated that arrestin's role in ERK activation varies, indicating a nuanced influence of ligand structure.

Cite This Study

Huang et al. (2026) studied this question.

synapsesocial.com/papers/69f5949771405d493afff6d7https://doi.org/10.4062/biomolther.2025.255
View Full Paper
Ask AI
Bookmark
Share